Cargando…
Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
Tuberculosis (TB) remains a leading global health problem that is aggravated by emergence of drug-resistant strains, which account for increasing number of treatment-refractory cases. Thus, eradication of this disease will strongly require better therapeutic strategies. Identification of host factor...
Autores principales: | Ndlovu, Hlumani, Marakalala, Mohlopheni J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075764/ https://www.ncbi.nlm.nih.gov/pubmed/27822210 http://dx.doi.org/10.3389/fimmu.2016.00434 |
Ejemplares similares
-
Dectin-1-Syk-CARD9 Signaling Pathway in TB Immunity
por: Wagener, Matthew, et al.
Publicado: (2018) -
Signaling C-type lectin receptors in antimycobacterial immunity
por: Marakalala, Mohlopheni J., et al.
Publicado: (2017) -
Mechanistic insights into antiretroviral drug‐induced liver injury
por: Pillaye, Jamie N., et al.
Publicado: (2020) -
Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
por: Mpotje, Thabo, et al.
Publicado: (2023) -
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
por: Guler, Reto, et al.
Publicado: (2021)